tiprankstipranks

Melanie Groleau Insider Profile

4 Followers
Melanie Groleau, Senior Officer at Knight Therapeutics, holds 10.39K shares in Knight Therapeutics (Ticker: KHTRF). Most recently, Melanie Groleau Sold 48,709 shares of Knight Therapeutics on Jun 11, 2026 for an estimated value of $450.56K.
tipranks
Melanie  Groleau

Melanie Groleau
Knight Therapeutics (KHTRF)
Senior Officer

Not Ranked
Melanie Groleau has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$75K
100.00%
A breakdown of Melanie Groleau's holdings

Insider Roles

Knight Therapeutics
(KHTRF)
Senior Officer
Roles that Melanie Groleau holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Melanie Groleau

Melanie Groleau's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Knight Therapeutics
Jun 11, 2026
Senior Officer
Informative Sell
450.56K
$74.87K
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Apr 05, 2025
Uninformative Sell
C$16.97K
2,751
C$6.17
Mar 28, 2026
Uninformative Sell
C$29.40K
4,587
C$6.41
Jun 11, 2026
Informative Sell
C$450.56K
48,709
C$9.25
List of latest transactions for each holding click on a transaction to see Melanie Groleau's performance on stock

Melanie Groleau insider profile FAQ

What is the percentage of profitable transactions made by Melanie Groleau?
The percentage of profitable transactions made by Melanie Groleau is ―.
    What is the average return per transaction made by Melanie Groleau?
    The average return per transaction made by Melanie Groleau is ―.
      What stocks does Melanie Groleau hold?
      Melanie Groleau holds: KHTRF stocks.
        What was Melanie Groleau’s latest transaction?
        Melanie Groleau latest transaction was an Informative Sell of $450.56K.
          What was Melanie Groleau's most profitable transaction?
          Melanie Groleau’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Melanie Groleau's role in Knight Therapeutics?
            Melanie Groleau's role in Knight Therapeutics is Senior Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.